How can biomarkers help doctors detect disease at an early stage?

In the context of translational medicine, biomarkers are measurable biological parameters—such as proteins, genetic mutations, or specific mRNA levels—that serve as indicators of a particular physiological or disease state.1

Biomarkers facilitate early disease detection by allowing clinicians to identify pathological changes before a condition reaches an advanced stage, which is critical for improving patient prognosis and enabling timely intervention. They function in several ways:1

• Direct Detection: Biomarkers can be substances secreted by a malignancy or specific physiological responses to a disease that are detectable in easily accessible body fluids like serum, saliva, or urine.1
• Diagnostic Imaging and Testing: Advances in diagnostic imaging and sensitive laboratory methods allow doctors to measure these markers. For example, spinal fluid analysis can identify signatures of Alzheimer disease in patients with mild cognitive impairment, providing a window for early treatment.2
• Pattern Analysis: Because individual biomarkers can be nonspecific, researchers use bioinformatics to analyze patterns of multiple proteins simultaneously, creating a more specific disease index to distinguish between healthy and diseased states.1

By integrating these molecular tools into clinical practice, translational medicine aims to close the gap between laboratory discovery and patient care.3